HP0788 LD 1150 |
Session - 127th Maine Legislature C "A", Filing Number H-183, Sponsored by
|
LR 476 Item 2 |
|
Bill Tracking, Additional Documents | Chamber Status |
Amend the bill in section 1 in subsection 12 in paragraph B in the 3rd line (page 1, line 20 in L.D.) by striking out the following: " 3" and inserting the following: ' 2'
Amend the bill in section 1 in subsection 12 by striking out all of paragraph H (page 2, lines 30 to 32 in L.D.) and inserting the following:
SUMMARY
This amendment is the majority report of the committee. The amendment provides that a pharmacy benefits manager may set a maximum allowable cost for a prescription drug only if that drug is nationally available and has 2 or more nationally available therapeutically equivalent drug substitutes with a significant cost difference rather than 3 or more as provided in the bill. The amendment also replaces the provision in the bill authorizing the Superintendent of Insurance to enforce violations with a provision granting a pharmacy the right to request mediation by a private mediator to resolve disagreements related to maximum allowable cost pricing.
The amendment specifies that the provisions apply to contracts between a pharmacy and a pharmacy benefits manager executed or renewed on or after January 1, 2016.